Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study seeks better ways to diagnose and predict inflammatory bowel disease

NCT ID NCT05414578

Knowledge-focused Sponsor: University of Southern Denmark Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 366 adults referred for suspected inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. The goal was to find simple, non-invasive markers that can help doctors diagnose IBD more accurately and predict how the disease will progress. By improving early diagnosis and prognosis, researchers hope to reduce complications and improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

366 people

The number who actually took part.

Started

Feb 2022

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients referred to the hospital on suspicion of IBD

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

To be included in the study, the participants must meet the following criteria: Inclusion Criteria: * Referred on the suspicion of inflammatory bowel disease * Adult (+18 years of age) * Written informed consent to participate in the study Exclusion Criteria: * A previous known diagnosis of Crohn's disease, ulcerative colitis or IBD-U * Unable to provide informed consent * Unable to comply with protocol requirements (e.g., for reasons including alcohol and/or recreational drug abuse)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Crohn disease (CD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Crohn disease disease inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Crohn disease (CD) Inflammatory bowel diseases (IBD) Ulcerative colitis (UC)

Contacts and locations

Locations

  • Akademiska Sjukhuset Uppsala

    Uppsala, Region Uppsala, 75185, Sweden

  • Ersta Sjukhus

    Stockholm, 11691, Sweden

  • Höglandssjukhuset Eksjö

    Eksjö, Region Jönköpings Län, 57581, Sweden

  • Karolinska Universitetssjukhuset

    Stockholm, Region Stockholm, 17176, Sweden

  • Landspitali

    Reykjavik, 101, Iceland

  • OUH Svendborg Hospital

    Svendborg, Denmark

  • Odense University Hospital

    Odense, Denmark

  • Oslo Universitetssykehus

    Oslo, 0424, Norway

  • SLB Vejle Hospital

    Vejle, Denmark

  • SVS Esbjerg Hospital

    Esbjerg, Denmark

  • Sykehuset i Telemark

    Skien, 3710, Norway

  • Sykehuset i Vestfold

    Tønsberg, 3103, Norway

  • Universitetssjukhuset i Linköping

    Linköping, Region Östergötland, 58185, Sweden

  • Universitetssjukhuset Örebro

    Örebro, Örebro County, 70185, Sweden

  • University Hospital of Southern Denmark

    Aabenraa, 6200, Denmark

  • Vestre Viken HF

    Drammen, 3004, Norway

  • Østfold Kalnes

    Grålum, 1714, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.